Systemic lupus erythematosus is a multi-organ disease with a high predilection for kidneys. The complement system has been described as a marker of disease activity, and within the approach to glomerulonephritis, complement consumption is assumed to exist. There are no studies in Latin America that describe outcomes related to complement consumption in patients with confirmed lupus nephritis through biopsy.